| Douglas Aumiller Fairbairn, MD | |
|
6816 Otis St, Arvada, CO 80003-4067 | |
| (303) 420-7724 | |
| (303) 420-9349 |
| Full Name | Douglas Aumiller Fairbairn |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 6816 Otis St, Arvada, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407846009 | NPI | - | NPPES |
| 01246495 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 24649 (Colorado) | Primary |
| Entity Name | Inner City Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578539979 PECOS PAC ID: 4688562697 Enrollment ID: O20040310000093 |
News Archive
WebMD Health Corp. announced today that it has commenced a tender offer to purchase up to 3,000,000 shares of its common stock at a price of $52.00 per share. The price per share of $52.00 represents a change from the price per share of $50.00 that WebMD previously announced on August 5, 2010.
Link Resources, Inc. announced today the completion of a share exchange transaction and concurrent US$12 million private placement pursuant to which it acquired the parent company of Yantai Bohai Pharmaceuticals Group Co., Ltd. ("Bohai").
Smooth, radiant skin with just a click of a laser sounds like a dream come true for many people. But how many sessions does it take to get results and how long do you have to hide from your friends?
Jasco Pharmaceuticals, LLC has initiated a collaborative research program with North Carolina Central University in Durham, North Carolina, focused on developing therapeutics for pancreatic cancer that function through a Pim kinase mechanism of action.
Cerenis Therapeutics, a biopharmaceutical company focused on discovering and developing novel HDL therapies, today announced the completion of a Phase 1 study of the Company's CER-001 investigational product candidate to treat patients with acute coronary syndromes. Results of the completed study provide evidence that the investigational therapy was safe and well-tolerated at all dose levels evaluated, including those intended for future clinical development.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas Aumiller Fairbairn, MD 1978 S Garrison St, 101, Lakewood, CO 80227-2282 Ph: (303) 988-1559 | Douglas Aumiller Fairbairn, MD 6816 Otis St, Arvada, CO 80003-4067 Ph: (303) 420-7724 |
News Archive
WebMD Health Corp. announced today that it has commenced a tender offer to purchase up to 3,000,000 shares of its common stock at a price of $52.00 per share. The price per share of $52.00 represents a change from the price per share of $50.00 that WebMD previously announced on August 5, 2010.
Link Resources, Inc. announced today the completion of a share exchange transaction and concurrent US$12 million private placement pursuant to which it acquired the parent company of Yantai Bohai Pharmaceuticals Group Co., Ltd. ("Bohai").
Smooth, radiant skin with just a click of a laser sounds like a dream come true for many people. But how many sessions does it take to get results and how long do you have to hide from your friends?
Jasco Pharmaceuticals, LLC has initiated a collaborative research program with North Carolina Central University in Durham, North Carolina, focused on developing therapeutics for pancreatic cancer that function through a Pim kinase mechanism of action.
Cerenis Therapeutics, a biopharmaceutical company focused on discovering and developing novel HDL therapies, today announced the completion of a Phase 1 study of the Company's CER-001 investigational product candidate to treat patients with acute coronary syndromes. Results of the completed study provide evidence that the investigational therapy was safe and well-tolerated at all dose levels evaluated, including those intended for future clinical development.
› Verified 8 days ago
Dr. Tod Sweeney, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 6390 Gardenia St, Suite 140, Arvada, CO 80004 Phone: 720-898-1110 Fax: 720-898-1113 | |
Dr. David Glasscock, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7950 Kipling St, Ste 101, Arvada, CO 80005 Phone: 303-425-4680 Fax: 303-425-1616 | |
Dr. Patricia Mladenov, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7380 W 52nd Ave, Unit I, Arvada, CO 80002 Phone: 303-463-5941 Fax: 303-463-5941 | |
Dr. Steve D. Stahl, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 7950 Kipling St Ste 101, Arvada, CO 80005 Phone: 303-425-4680 Fax: 303-425-1616 | |
Troy Curtis, MD, MPH Family Medicine Medicare: Medicare Enrolled Practice Location: 8850 Ralston Rd Ste 102, Arvada, CO 80002 Phone: 720-961-5114 | |
Kristin Doig, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 12001 W 63rd Pl, Arvada, CO 80004 Phone: 303-423-1360 | |
Jon Glenn Shick, DO LLC Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7850 Vance Dr, #185, Arvada, CO 80003 Phone: 303-423-0535 Fax: 303-422-3881 |